Such robust tumor suppressor upregulation in response to oncogenic stimulus specifically in young mice could represent an additional cancer progression barrier not available to older cells that already have high levels of expressed p16Ink4A, p19Arf, and p21Cip1 prior to oncogene activation. The gene discussed is CDKN2A; the disease is cancer.